µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ TxjYrzC
)c n+1R
ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ McH>"`
9{k97D/
¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ )'17r82a
%~L>1ShtU
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© QO;N9ZI
/Jf.y*;
1. CD4 \%PaceH
ku$$ 1xq
2. T cell receptor(TCR) Tc8un.
BdlVabQyKW
3. immunoglobulin superfamily (IgSF) I2nF-JzD2a
yjfat&$
4. selectin mPI8_
5V8]
^O^l(e!3
5. anti-idiotypic antibody (¦ÁId) U2uF&6v
.>Ljnk
6. major histocompatibility complex(MHC)
;"(foY"L
?5_7;Ha
7. immunotolerance _g1b{$
UnI48Y
8. biological reponse modifier(BRM) 0-~\
W(
x| yEtO&
9. immune reponse gene (Ir gene) ;&1V0U,fx
nstUMr6
10. reshaped antibody (or reconstituted antibody) \[Z?&
^]{R.(#z
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© } CeCc0M
G:zua`u[
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ #1>X58I^
]T%rjsN
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? **}h&k&%2
FJ asS8
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ G "73=8d
YW{C} NA
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? Fd0%lnui
"HPB!)C8(
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) 66fO7OJs
5}`_x+$%(`
¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ H,b5C_D29
=
jN*P?
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? k+ze74_"
^<e.]F25M
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? =Q.^c.sw
7}X[
4("bB
¡¡ U~pV) J
?mwD*LN3o
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ {~F4WjHJp
|`cKD >
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? hNzB4p
?]*^xL;x?
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? 2sJ(awN>
1;{Rhu7*
k
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ hRCed4qA
]
wtb-PC
ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ o#skR4lwe
oZAB _A)[-
¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ #W|'1
OX4
m&?#;J|B$
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© cZ|\.0-
hC\6-
0u
1. CD8 Qc pm!
G%s2P.cd
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) GSRVe/[
JhLgCnm
3. immunoglobulin fold(Ig fold) ' hs2RSq
D}mjN=Y
4. cadherin (Ca-dependent cell adhesion moleculers) +1D+]*t_?[
HBMhtfWW
5. idiotype-anti-idiotypic antibody immune network theory ;S>])5<
h]TQn)X]
6. HLA class II antigen 7D;cw\ |
tfGHea)M
7. complementarity-determining region (CDR) 1#ft#-g}
apu4D
Ay&8
8. perforin(or pore-forming protein ,PFP) nuw70*ell
#n#@fAY
9. high affinity IL-2 receptor
b4QI)z
8]U{;|';
10. artificial active immunization 1fZ(l"
Y9&,t\ q
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© o}* hY"&
s;6CExH
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠc1E'$
-
K@
|v({-*7
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 Z\k&gio5C^
/N&CaH\;^$
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ 1*@'-mj
&M.66O@
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ ,f[>L|?e
j4cwI90=
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) Ndi9FD3im
]hFW73FV
1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ v#U"pn|M
H*$jc\
dC
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? a- |*?{o
.MP !`
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ TX&Jt%
YLiSbLz1
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ?'KL11@R
LC'{p
¡¡ }MH0L#Tu
`s8{C
b=}1
g.zEn/SM
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ J
/f
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ VCD:3U
8
no9;<]4
¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ WRrd'{sB
B
#.L
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 93`
AWg/T
X;"Sx#U
1. immunoglobulin gene rearrangement s#)5h0t#du
'>' wK.
2. the common chain of cytokine receptor (or a cytokine receptor !AKg m'Nw
?MgUY)X
subunit shared by some cytokine receptors) >76\nGO
g!+|I
3. flow cytometry(FCM) #py[
^`)) C;
4. carrier effect
uFPF!Ern
T^~5n6
5. positive selection of T lymphocytes in thymus ~
==>pj
n=c
2K
c
6. mouse TH1(Th1) and TH2(Th2) subsets \8?Tdx=
83
Q4On
7. perforin (pore-forming protein ,PFP) CJJzCVj
9&`
2V
8. ADCC(antibody-dependent cell-mediated cytotoxicity) D-4f >
lMg+R<$~I
9. SH-2(src-homology region 2) Qg[/%$x.
VI'hb'2
10. Ab2¦Â (internal image) w &(|e <
[`rba'
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© V&\[)D'c
i* NH'o/
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? $l|qk z
(KF=On;=Y
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? N,;5{y1;J
YtfVD7m
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠ_J?
Dq
^]a #7/]o
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ "t_-f7fS7
A?t%e
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠUM6(s@$
*UmI]E{g3(
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) M #=]
k
4y'OMRy
ÃâÒßѧרҵ£º (m:Zk$
Hqn#yInA7~
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ x`dHJq`_g
km1~yQ"bH
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? P}TI
q#
T<w5vqFDu
´«È¾²¡Ñ§×¨Òµ£º yz LpK;
eZdu
2.;<
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ HOE_S!N
'toa@5
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ (Xq)p y9
TT4./R:
Ïû»¯×¨Òµ£º 1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ )p~BQ~eip;
]):<ZsT
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? "Za>ZRR
bV$)!]V
krC{ed
Mc%Nf$XQ
R&Jm
+3N
8&3V#sn'
E
gal4
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ "9^j.
k-HCeZ
ÃâÒßѧÊÔÌâ b r^_'1
lI-L`
x
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© i 4%xfN
Sk:ws&D1u
1. Fas(CD95)/FasL .Y3pS/VI
y6IXd W
2. common chain of cytokine receptor yfx7{naKC`
&Ibu>di4[
3 . TCR/CD3 complex E2"q3_,,
N^pJS6cJkl
4. negaive selection of thymocytes q@@T]V6
`S2[5i
5. artificial active immune B:e
@0049
O=$~O\}b
6. anti-idiotypic <HJl2p N
lNL6M%e$Q
7. IgSF 0MkSf*
"v`
8. Integrin g-e#!(
XvE9b5}
9. chemokine rN%F)
q#
>2Jdq
10. B7/CD28 :^fcC[$K
>zhO7,=,
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© C%U`"-%n@7
:sP!p`dl
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ h~(D@/tB
0%Z]h?EYy|
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ ]miy/V }5
A5H3%o(6k
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ ]b= P=
ylB7* >[
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ -CR?<A4mud
2Y>~k{AN%
kdCP
3 HIz9F(
OKP9CLg9
,i0b)=!o
f_imyzP
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ \/SQ,*O
Ht-t1q
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© C-?%uF
S<L.c
1. B7/CD28 <97d[/7i
Z1h
]
2. Th1 subset AxZD-|.
[ G
e=kFB
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© v"MX>^/<
D!oc>K$B
4. antibody affinity maturation %',F
H%1$,]F
5. AP-1 2o9$4{}rG
&I({T
`=
6. single chain variable fragment£¨ScFv£© r,]#b[:.s|
"GQl~
7. NK cell receptor S#b-awk
>;#=gM
8. Zinkernagel-Doherty phenomenon 8LI-gp\ 2
';G1A
9. Ig fold kip`Myw+
Otz E:qe
10. CD40/CD40L +xXH2b$wWC
Dl&GJ`&:p
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© !~ZP{IXyo
axk"^gps
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ $2MAZGJV
\@~UDP]7
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ e/8z+H^H
a1.|X i'/z
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ -.<k~71
O%f8I'u$
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ U{ ;l0 2S
o\`>c:.
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ 70B)|<$
e9^2,:wLB
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ kzq29S
.9|uQEL
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ #*c F8NV-
p{=QGrxB*
M]H
gIL@9#
gcJF`H/iNK
[ut#:1h^
!7U\J]
]$M<]w,IJ2
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ eeUp 1g
^+R:MBK
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© 3^
.8.q(6
qUf)j\7"Fn
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© DI&MC9j(
]=D5p_A(
1.Co-stimulators (or co-stimulating molecules) y~F<9;$=
5]7&IDA]]9
2.NK-kB {@r*+~C3
`<j_[(5yb
3.Immunoglobulin superfamily C$#W{2x%6
-{9Gagy2&
4.antigen-presenting cell (APC) .yVnw^gu
5#_tE<uM
5.death domain o&^NwgRCF
9B)lGLL}q
6.CCR and CXCR V2yveNz\7
_2jw,WKr
7.Lectin (or mitogen) HR3_@^<7
[F|+(}
8.Clusters of differentiation, CD) ygvzdYd
JfTfAq]
9.B7 family $o^e:Y,
a
Sl.o,W^
10.Cytotoxic T lymphocyte, CTL)
#
[ :w
S!7g)
11.IL-15 and IL-15 receptor (IL-15R) 55hyV{L%
d,R6` i
12.MHC restriction /Dw@d,&[
+v[O
13.Affinity-chromatography :^G%57NX
Dq`~XS*
14.Cyctosprin A, CsA uMDtdC8
N?+eWY
15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
_>v0R
'
?f@ 9n ph
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© )nnCCRS6
=xBT>h;
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 y#bK,}
hrT%XJl
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ q5?L1
JmjxGcG
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ DoG%T(M!a9
&
Y=.D:z<
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© ?{j@6,
C.HYS S
ÃâÒßѧרҵ£º 2C{/`N
&<=e_0zT
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ ixzTJ]y u
/4H[4m]I
Ïû»¯ÄÚ¿Æ£º ,$BgR2^
qM*S*,s
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ 0T1ko,C!,e
x?rbgsB5&
ѪҺ²¡Ñ§×¨Òµ£º %awVVt{aG
9,w}Xe=C
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ .P8-~?&M
rWqkdi1
Kc-Y
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ u2\+?`Ox
}U(\~
=D
(רҵ»ù´¡: ÃâÒßѧ) (GnVwJ<v9V
=p5?+3"@
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) %
<^[j^j}o
8i["
.9}G\
1. ADCC(antibody dependent cell-mediated cytotoxicity) ;FcExg|k
db<q-u
2. »·æß¾úËØ(cyclosporin) _IC,9bbg
jT{f<P0
3. KIR(killer cell inhibitory receptor) 32s5-.{c/f
v3?kFd7%H~
4. HLDA(human leucocyte differentiation antigen) "$]ls9-%n
k?
o^5@b/
5. Interleukin 18(IL-18) V;H
d)v(j
l_bL,-|E8
6. ÕûºÏËØ(integrin) +g)_4fV0|
#NWZ k.S
7. Fas/FasL Z+r%_|kZ
_
yiRh:
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) /3OC7!~;fM
sKe,
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) &$<(D0
~g*Y,
Y
10. Th1/Th2 O~$ {&(
3w
t:5
Im
11. »ùÒòÒßÃç(DNAÒßÃç) @>M8Pe
v&p,Clt-2
12. chemokines and chemokine receptor wEBtr
e7
+8Of-ZUx
13. ÃâÒßÄÍÊÜ 8.*\+nH
K~`n}_:
14. ¹²´Ì¼¤·Ö×Ó "}0)YRz%
Y8D7<V~Md
15. ËÀÍö½á¹¹Óò(death domain) Ko1AaX(I'+
->#y(}
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) =$^Wkau
Aqa6R+c
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? ]jHgo](%
/d{glOk
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óᣠ=#OHxM
aSn0o_4bD
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î [54@i rH
A6{t%k~F
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ Q
mb[ e>
.'l.7t
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå e*Uz#w:
DCEvr" (
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ y3&Tv
>Sc$R0
3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£